HALO fund manager activity
Halozyme Therapeutics, Inc · Nasdaq. Reported by 7 tracked fund managers in their 13F filings, Q4 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 427,713 | $33,477,096 | 0.01% | Aug 4, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 739,273 | $57,862,898 | 0.13% | Aug 14, 2026 |
| Richard Pzena - Pzena Investment Management | No change | 4,049 | $316,915 | 0.00% | Aug 7, 2026 |
| Torray Funds | Added | 38,703 | $3,029,284 | 0.41% | Jul 30, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Ken Fisher - Fisher Asset Management | Trimmed | 444,689 | $28,740,249 | 0.01% | May 5, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 746,841 | $48,268,334 | 0.15% | May 15, 2026 |
| Richard Pzena - Pzena Investment Management | Trimmed | 4,049 | $261,687 | 0.00% | Apr 24, 2026 |
| Torray Funds | Added | 38,179 | $2,467,509 | 0.36% | May 1, 2026 |
Older quarters